August 26, 2015, Wednesday, 16:01 REPUBLIC //
Photo: Press office of the NGO” Microgen »
UVA, Aug 26, 2015 / IA “Bashinform” Arina Rahimkulova /. Ufa specialists of pharmaceutical companies “Immunopreparat” have developed a new vaccine against influenza. The drug, invented in the Ufa branch of the NPO “Microgen”, this year will be used for the free vaccination of the population in the national calendar of preventive vaccinations.
Clinical trials “Sovigrippa” showed no toxicity and fever with a good ability to form specific immunity against the influenza virus. The new vaccine is designed for the active immunization, preventive yearly seasonal flu in people aged 18 to 60 years.
«Over 15.5 million Russians will be able to protect against the new influenza virus vaccine proven expressed immunogenic activity, good tolerance, high security and sustainable preventive efficacy. “Sovigripp” is entirely Russian design and is produced without the use of foreign components. In its development, and the establishment of production, the company invested about 200 million rubles, “- said General Director of NPO” Microgen “Peter Kanygin.
immunobiological drugs received approval and recommendation of the Russian medical community. For the development of ‘flu vaccine and its method of preparation “patent NPO” Microgen “was awarded the diploma of the Federal Service for Intellectual Property in the” 100 best inventions of Russia “, the press service of the company.
No comments:
Post a Comment